| Dr Benjamin D Klibanoff, OD | |
|
55 Broad St, Pawtucket, RI 02860-2023 | |
| (401) 723-3400 | |
| Not Available |
| Full Name | Dr Benjamin D Klibanoff |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 14 Years |
| Location | 55 Broad St, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053611996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | CODTG00551 (Rhode Island) | Primary |
| 152W00000X | Optometrist | 4822 (Massachusetts) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Klibanoff Eye Associates, Ltd | 6002993045 | 2 |
News Archive
A new UCLA study finds that doctors who follow guidelines recommending the delay of antiretroviral therapy for non-adherent HIV patients are likelier to put off that treatment for Latinos, women and poor patients than they do for others. In addition, doctors are slower to prescribe protease inhibitors for African American patients whether or not the physician follows the guidelines.
St. Louis Beacon: Nixon Says Tax Cut Bill Removes Missouri's Sales Tax Break For Prescription Drugs. Gov. Jay Nixon has upped the ante in his criticism of a broad-based tax cut bill awaiting his decision, saying Thursday that it removes a sales tax exemption for prescription drugs that will raise taxes for millions of Missourians. One sponsor of the bill says there's plenty of time for the legislature to correct what he deemed a drafting error (Rosenbaum, 5/30).
With the incidence of kidney failure on the increase in this country, it is timely that the NZ Kidney Foundation has recently awarded a $76,000 grant to Professor Zoltan Endre to further research into renal failure. The grant is the largest single amount awarded by the NZ Kidney Foundation and has been largely funded from funds donated via an ongoing nationwide telephone appeal.
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.
Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca's chemical compound library to identify those which trigger a key element of cancer cell ageing - called senescence.
› Verified 8 days ago
| Provider Name | Klibanoff Eye Associates, Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467508556 PECOS PAC ID: 6002993045 Enrollment ID: O20080521000539 |
News Archive
A new UCLA study finds that doctors who follow guidelines recommending the delay of antiretroviral therapy for non-adherent HIV patients are likelier to put off that treatment for Latinos, women and poor patients than they do for others. In addition, doctors are slower to prescribe protease inhibitors for African American patients whether or not the physician follows the guidelines.
St. Louis Beacon: Nixon Says Tax Cut Bill Removes Missouri's Sales Tax Break For Prescription Drugs. Gov. Jay Nixon has upped the ante in his criticism of a broad-based tax cut bill awaiting his decision, saying Thursday that it removes a sales tax exemption for prescription drugs that will raise taxes for millions of Missourians. One sponsor of the bill says there's plenty of time for the legislature to correct what he deemed a drafting error (Rosenbaum, 5/30).
With the incidence of kidney failure on the increase in this country, it is timely that the NZ Kidney Foundation has recently awarded a $76,000 grant to Professor Zoltan Endre to further research into renal failure. The grant is the largest single amount awarded by the NZ Kidney Foundation and has been largely funded from funds donated via an ongoing nationwide telephone appeal.
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.
Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca's chemical compound library to identify those which trigger a key element of cancer cell ageing - called senescence.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin D Klibanoff, OD 55 Broad St, Pawtucket, RI 02860-2023 Ph: (401) 723-3400 | Dr Benjamin D Klibanoff, OD 55 Broad St, Pawtucket, RI 02860-2023 Ph: (401) 723-3400 |
News Archive
A new UCLA study finds that doctors who follow guidelines recommending the delay of antiretroviral therapy for non-adherent HIV patients are likelier to put off that treatment for Latinos, women and poor patients than they do for others. In addition, doctors are slower to prescribe protease inhibitors for African American patients whether or not the physician follows the guidelines.
St. Louis Beacon: Nixon Says Tax Cut Bill Removes Missouri's Sales Tax Break For Prescription Drugs. Gov. Jay Nixon has upped the ante in his criticism of a broad-based tax cut bill awaiting his decision, saying Thursday that it removes a sales tax exemption for prescription drugs that will raise taxes for millions of Missourians. One sponsor of the bill says there's plenty of time for the legislature to correct what he deemed a drafting error (Rosenbaum, 5/30).
With the incidence of kidney failure on the increase in this country, it is timely that the NZ Kidney Foundation has recently awarded a $76,000 grant to Professor Zoltan Endre to further research into renal failure. The grant is the largest single amount awarded by the NZ Kidney Foundation and has been largely funded from funds donated via an ongoing nationwide telephone appeal.
Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.
Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca's chemical compound library to identify those which trigger a key element of cancer cell ageing - called senescence.
› Verified 8 days ago
Dr. Jonathan D Kaplan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2 Dexter St, Pawtucket, RI 02860 Phone: 401-723-9540 Fax: 401-725-6583 | |
Dr. Kenneth A Kaplan, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2 Dexter St, Pawtucket, RI 02860 Phone: 401-723-9540 Fax: 401-725-6583 | |
Glenn S. Prescod, M.d., M.p.h., Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 333 School St, Suite 301, Pawtucket, RI 02860 Phone: 401-725-3600 Fax: 401-728-8760 | |
Modern Eyes Llc Optometrist Medicare: Medicare Enrolled Practice Location: 145 Newport Ave, Pawtucket, RI 02861 Phone: 401-524-4025 | |
David Klibanoff, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 121 Broad St, Pawtucket, RI 02860 Phone: 401-723-3400 Fax: 401-727-2326 | |
Dr. Peter J Liberto, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 145 Newport Ave, Pawtucket, RI 02861 Phone: 401-729-0200 Fax: 401-729-0222 |